How much of NXP Semiconductors'stock is owned by insiders?
In the past three months, NXP Semiconductors insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,579,824.00 in company stock. Only 0.32% of the stock of NXP Semiconductors is held by insiders. 87.13% of the stock of NXP Semiconductors is held by institutions.
Where can I buy shares of NXP?
Shares of NXP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Who is NXP Semiconductors NV?
Analyst Report: NXP Semiconductors NV NXP Semiconductors N.V. provides a wide range of semiconductor products.
Is NXP Semiconductors in the S&P 500?
The shares are a component of the S&P 500. Analyst Report: NXP Semiconductors NV NXP Semiconductors N.V. provides a wide range of semiconductor products.
Is NXP stock a buy?
The NXP Semiconductors N.V. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock.
Is NXP a good stock?
The financial health and growth prospects of NXPI, demonstrate its potential to outperform the market. It currently has a Growth Score of A. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.
Is NXP Semiconductors A Buy Sell or Hold?
NXP Semiconductors has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 9 buy ratings, 7 hold ratings, and 1 sell rating.
Why is NXP stock going down?
NXP Semiconductor (NASDAQ:NXPI) shares are dropping in early Thursday trading after Piper Sandler downgraded the stock and cut its price target on concerns over the broader automotive sector, which could result in slowing growth for the Dutch semiconductor manufacturer.
What is NXP known for?
Today, NXP creates semiconductors, system solutions, and software that deliver better sensory experiences to consumers using mobile phones, personal media players, TVs, set-top boxes, identification applications, in-car entertainment, and a wide range of other electronic devices and systems.
Did nexperia buy NXP?
Following the transaction, Nexperia became an independent company, and the entire scope of the NXP Standard Products business, including its management team, led by Frans Scheper, and approximately 11,000 NXP employees were transferred to Nexperia.
Does NXP outsource manufacturing?
Like many other chipmakers, NXP doesn't manufacture all of its semiconductors in-house, instead outsourcing production to suppliers such as Taiwan Semiconductor Manufacturing Co.
What sector is NXPI?
SemiconductorsKey DataLabelValueSectorTechnologyIndustrySemiconductors1 Year Target$210.00Today's High/Low$149.53/$143.3414 more rows
Is NXP fabless?
NXP is a non-fabless company which means it manufactures its own semiconductor chips rather than outsourcing it to a fab.
Who is buying Nxpi?
An Asian Tech Press report states that Samsung plans to acquire NXP Semiconductors (NXPI). No further details about the potential deal were disclosed. Shares of NXPI stock are down 19% year-to-date, but up more than 4% on the news.
Should I buy or sell NXP Semiconductors stock right now?
18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NXP Semiconductors in the last year. There are currentl...
What is NXP Semiconductors' stock price forecast for 2022?
18 brokerages have issued 1 year price targets for NXP Semiconductors' stock. Their NXPI stock forecasts range from $160.00 to $320.00. On average,...
How has NXP Semiconductors' stock price performed in 2022?
NXP Semiconductors' stock was trading at $227.78 at the beginning of 2022. Since then, NXPI shares have decreased by 21.6% and is now trading at $1...
When is NXP Semiconductors' next earnings date?
NXP Semiconductors is scheduled to release its next quarterly earnings announcement on Monday, August 1st 2022. View our earnings forecast for NXP...
How were NXP Semiconductors' earnings last quarter?
NXP Semiconductors (NASDAQ:NXPI) posted its quarterly earnings results on Monday, May, 2nd. The semiconductor provider reported $3.11 earnings per...
How often does NXP Semiconductors pay dividends? What is the dividend yield for NXP Semiconductors?
NXP Semiconductors announced a quarterly dividend on Thursday, June 2nd. Investors of record on Wednesday, June 15th will be given a dividend of $0...
Is NXP Semiconductors a good dividend stock?
NXP Semiconductors(NASDAQ:NXPI) pays an annual dividend of $3.38 per share and currently has a dividend yield of 1.89%. NXP Semiconductors has been...
What guidance has NXP Semiconductors issued on next quarter's earnings?
NXP Semiconductors updated its second quarter 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of for t...
Who are NXP Semiconductors' key executives?
NXP Semiconductors' management team includes the following people: Mr. Kurt Sievers , Pres, CEO & Exec. Director (Age 53, Pay $4.6M) ( LinkedIn...
Wealth Dimensions Group, Ltd. Buys iShares Core U.S. ..
Moisand Fitzgerald Tamayo, LLC Buys Dimensional International Core Equity Market ETF, Avantis ..
Investment company Wealth Dimensions Group, Ltd. (Current Portfolio) buys iShares Core U.S.
Danda Trouve Investment Management, Inc. Buys PIMCO Enhanced Short Maturity Active ..
Investment company Moisand Fitzgerald Tamayo, LLC (Current Portfolio) buys Dimensional International Core Equity Market ETF, Avantis International Small Cap Value ETF, Dimensional Emerging Core Equity Market ETF, Avantis U.S.
Why NXP stock fell after the chip maker reported an earnings beat
Investment company Danda Trouve Investment Management, Inc. (Current Portfolio) buys PIMCO Enhanced Short Maturity Active Exchange-Trad, Schwab U.S.
Sightline Wealth Advisors, LLC Buys iShares 0-5 Year TIPS Bond ETF, ARK Genomic Revolution ETF, ..
Truist Securities Managing Director Will Stein joins Yahoo Finance Live to discuss NXP earnings, its share buyback program, and the outlook for chip shortages.
Lantz Financial LLC Buys Fidelity National Financial Inc, iShares MSCI USA ESG Optimized ETF, ..
Investment company Sightline Wealth Advisors, LLC (Current Portfolio) buys iShares 0-5 Year TIPS Bond ETF, ARK Genomic Revolution ETF, Nuveen Select Tax Free Income Portfolio, Global X Genomics & Biotechnology ETF, First Trust Morningstar Dividend Leaders Index Fun, sells PIMCO Income Strategy Fund II, PowerShares QQQ Trust Ser 1, iShares Core S&P 500 ETF, SPDR Nuveen Bloomberg Short Term Municipal Bond ET, Schwab US Aggregate Bond ETF during the 3-months ended 2021Q4, according to the most rece.
Coastal Investment Advisors, Inc. Buys Nuveen Select Tax Free Income Portfolio, Coinbase Global ..
Investment company Lantz Financial LLC (Current Portfolio) buys Fidelity National Financial Inc, iShares MSCI USA ESG Optimized ETF, Invesco BulletShares 2022 Corporate Bond ETF, BTC iShares MSCI EAFE Value ETF, BTC iShares MSCI EAFE Growth ETF, sells Invesco BulletShares 2021 Corporate Bond ETF, Blackrock Investment Quality Municipal Trust,, PayPal Holdings Inc, WisdomTree International LargeCap Dividend Index during the 3-months ended 2021Q4, according to the most recent filings of the investm.
What is the dividend payout ratio of NXP?
Investment company Coastal Investment Advisors, Inc.
How much does NXP make?
NXP Semiconductors does not yet have a strong track record of dividend growth. The dividend payout ratio of NXP Semiconductors is 33.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NXP Semiconductors will have a dividend payout ratio of 24.30% next year.
When is NXP earnings call?
NXP Semiconductors has a market capitalization of $54.64 billion and generates $8.61 billion in revenue each year. The semiconductor provider earns $52 million in net income (profit) each year or $6.78 on an earnings per share basis.
About Nuveen Select Tax-Free Income Portfolio
NXP Semiconductors will be holding an earnings conference call on Tuesday, August 3rd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.
0.0 Analyst's Opinion
Nuveen Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of United States.
How has Nuveen Select Tax-Free Income Portfolio's stock price been impacted by Coronavirus (COVID-19)?
There is not enough analysis data for Nuveen Select Tax-Free Income Portfolio.
Are investors shorting Nuveen Select Tax-Free Income Portfolio?
Nuveen Select Tax-Free Income Portfolio's stock was trading at $15.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NXP stock has decreased by 1.6% and is now trading at $15.08. View which stocks have been most impacted by COVID-19.
How often does Nuveen Select Tax-Free Income Portfolio pay dividends? What is the dividend yield for Nuveen Select Tax-Free Income Portfolio?
Nuveen Select Tax-Free Income Portfolio saw a decline in short interest during the month of January. As of January 15th, there was short interest totaling 4,300 shares, a decline of 66.7% from the December 31st total of 12,900 shares.
Is Nuveen Select Tax-Free Income Portfolio a good dividend stock?
Nuveen Select Tax-Free Income Portfolio declared a monthly dividend on Thursday, February 3rd. Shareholders of record on Tuesday, February 15th will be given a dividend of $0.0455 per share on Tuesday, March 1st. This represents a $0.55 dividend on an annualized basis and a yield of 3.62%.
Who are some of Nuveen Select Tax-Free Income Portfolio's key competitors?
Nuveen Select Tax-Free Income Portfolio pays an annual dividend of $0.55 per share and currently has a dividend yield of 3.65%. View Nuveen Select Tax-Free Income Portfolio's dividend history.
What is NRXP in medical field?
Some companies that are related to Nuveen Select Tax-Free Income Portfolio include Tekla Healthcare Investors (HQH), SPDR Bloomberg Barclays International Treasury Bond ETF (BWX), AllianceBernstein Global High Income Fund (AWF), iShares MSCI Hong Kong ETF (EWH), John Hancock Financial Opportunities Fund (BTO), BlackRock MuniYield Quality Fund III (MYI), Aberdeen Asia-Pacific Income Fund (FAX), Apollo Investment (AINV), Invesco Municipal Opportunity Trust (VMO), PIMCO High Income Fund (PHK), SLR Investment (SLRC), Templeton Global Income Fund (GIM), iShares MSCI Sweden ETF (EWD), Invesco Trust for Investment Grade Municipals (VGM) and Invesco Municipal Trust (VKQ). View all of NXP's competitors..
What is a nrx?
NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical stage biopharmaceutical company, today announced it is initiating clinical training of Nation of Georgia (Georgia) ICU physicians, in the use of intravenous ZYESAMI™ (Aviptadil- acetate) for emergency use in patients suffering with Critical COVID-19, and inhaled ZYESAMI™ for use in phase 2/3 clinical trials, for patients suffering with COVID-19.
Where are the Phase 3 trials of Cromos Pharma?
NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced today it has signed an agreement with MannKind Corporation to develop a dry powder formulation of ZYESAMI™ (aviptadil), a synthetic form of human Vasoactive Intestinal Peptide (VIP), produced by the body to help protect cells against inflammatory conditions.
Who is Chris Meekins?
Today, NRx Pharmaceuticals, Inc., (Nasdaq:NRXP) (NRx) through its Georgia subsidiary, announced that it has signed a master services agreement with Cromos Pharma, LLC, headquartered in Longview, Washington, to conduct phase 3 clinical trials of COVID-19 related drugs and vaccines in Central Europe and the Caucasus Region. The Senator Richard Lugar Research Institute, a US Government-funded regional research laboratory also serves as part of the collaboration. This region comprises a population of more than 500 million people, many of whom lack access to current COVID-19 vaccines and therapies.
